Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.65)
# 2,012
Out of 5,138 analysts
305
Total ratings
58.04%
Success rate
-0.97%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.68 | +49.25% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $4.71 | +27.39% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $469.29 | -9.44% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $8.60 | +39.53% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $43.33 | +54.63% | 3 | Sep 23, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $210 → $222 | $222.21 | -0.09% | 9 | Aug 28, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $148.85 | -3.26% | 15 | Aug 6, 2025 | |
| OMDA Omada Health | Initiates: Overweight | $25 | $16.12 | +55.09% | 1 | Jul 1, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Equal-Weight | $40 | $31.38 | +27.47% | 4 | Jun 11, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $196.74 | +6.74% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $199.88 | +0.06% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $2.39 | +109.21% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $57.77 | +97.33% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $35.06 | +62.58% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $74.70 | +8.43% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $41.26 | -15.17% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $16.55 | +8.76% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $80.11 | +130.93% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $241.01 | -30.71% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $154.39 | -72.80% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $189.49 | -16.09% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $78.60 | +59.03% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $351.71 | -79.44% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $191.58 | +1.79% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $331.02 | +47.42% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $191.40 | +54.65% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $270.87 | +35.86% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $273.28 | +87.72% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $272.21 | +1.02% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $45.75 | +92.35% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $60.33 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $91.02 | +103.25% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $237.11 | -10.17% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $161.93 | -64.18% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $300.25 | -61.03% | 15 | Jun 16, 2020 |
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.68
Upside: +49.25%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $4.71
Upside: +27.39%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $469.29
Upside: -9.44%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $8.60
Upside: +39.53%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $43.33
Upside: +54.63%
Veeva Systems
Aug 28, 2025
Maintains: Underweight
Price Target: $210 → $222
Current: $222.21
Upside: -0.09%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $148.85
Upside: -3.26%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $16.12
Upside: +55.09%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $31.38
Upside: +27.47%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $196.74
Upside: +6.74%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $199.88
Upside: +0.06%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $2.39
Upside: +109.21%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $57.77
Upside: +97.33%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $35.06
Upside: +62.58%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $74.70
Upside: +8.43%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $41.26
Upside: -15.17%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $16.55
Upside: +8.76%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $80.11
Upside: +130.93%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $241.01
Upside: -30.71%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $154.39
Upside: -72.80%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $189.49
Upside: -16.09%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $78.60
Upside: +59.03%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $351.71
Upside: -79.44%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $191.58
Upside: +1.79%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $331.02
Upside: +47.42%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $191.40
Upside: +54.65%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $270.87
Upside: +35.86%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $273.28
Upside: +87.72%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $272.21
Upside: +1.02%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $45.75
Upside: +92.35%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $60.33
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $91.02
Upside: +103.25%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $237.11
Upside: -10.17%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $161.93
Upside: -64.18%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $300.25
Upside: -61.03%